Dr. Tatyana Feldman, MD
Claim this profileHackensack University Medical Center
Expert in Lymphoma
Studies Hodgkin's Lymphoma
13 reported clinical trials
25 drugs studied
Area of expertise
1Lymphoma
Global LeaderStage IV
Stage III
Stage I
2Hodgkin's Lymphoma
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Tatyana Feldman, MD is currently running
SGN-35T
for Lymphoma
This trial is testing a new drug in adults with certain types of lymphoma that haven't responded to other treatments. The drug works by targeting a protein on cancer cells and delivering a substance that kills them. This drug has shown high selectivity against specific cancer cells and has been approved for treating lymphoma patients.
Recruiting1 award Phase 110 criteria
JCAR017
for Chronic Leukemia or Lymphoma
This trial tests JCAR017, a therapy using modified immune cells, in adults with hard-to-treat CLL or SLL. It aims to see if these enhanced immune cells can better fight the cancer.
Recruiting1 award Phase 1 & 2
More about Tatyana Feldman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Tatyana Feldman, MD has experience with
- Nivolumab
- Brentuximab Vedotin
- Doxorubicin
- Dacarbazine
- Rituximab
- Vinblastine
Breakdown of trials Tatyana Feldman, MD has run
Lymphoma
Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma
T-Cell Lymphoma
Peripheral T-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tatyana Feldman, MD specialize in?
Tatyana Feldman, MD focuses on Lymphoma and Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Tatyana Feldman, MD currently recruiting for clinical trials?
Yes, Tatyana Feldman, MD is currently recruiting for 5 clinical trials in Hackensack New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Tatyana Feldman, MD has studied deeply?
Yes, Tatyana Feldman, MD has studied treatments such as Nivolumab, Brentuximab Vedotin, Doxorubicin.
What is the best way to schedule an appointment with Tatyana Feldman, MD?
Apply for one of the trials that Tatyana Feldman, MD is conducting.
What is the office address of Tatyana Feldman, MD?
The office of Tatyana Feldman, MD is located at: Hackensack University Medical Center, Hackensack, New Jersey 07601 United States. This is the address for their practice at the Hackensack University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.